Metraipolis › archive › dc_5efeaabbc492

Baricitinib retention and factors associated thereof in clinical practice: a prospective, multicenter 12-month study in rheumatoid arthritis patients — Europe PMC PMID:42832028

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42832028
DOI: 10.1007/s00296-[numero omesso]-y
License (as archived): solo-consultazione
Archived: 2026-11-01T01:45:35.066Z
SHA-256 of the archived text: f1cf14e3951e5ed0dbb5592240414155e20632e167e303198265c343ad662a51
Stable URL of this page: https://metraipolis.com/documento/dc_5efeaabbc492

How to cite

Baricitinib retention and factors associated thereof in clinical practice: a prospective, multicenter 12-month study in rheumatoid arthritis patients — Europe PMC PMID:42832028 — Europe PMC (en), https://europepmc.org/article/MED/42832028 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5efeaabbc492 (Metraipolis archive dc_5efeaabbc492, sha256 f1cf14e3951e5ed0dbb5592240414155e20632e167e303198265c343ad662a51)

BibTeX

@misc{dc5efeaabbc492,
  title = {Baricitinib retention and factors associated thereof in clinical practice: a prospective, multicenter 12-month study in rheumatoid arthritis patients — Europe PMC PMID:42832028},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42832028},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5efeaabbc492; sha256 f1cf14e3951e5ed0dbb5592240414155e20632e167e303198265c343ad662a51},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42832028. Agents can read the archived copy with the MCP tool read_document.